Skip to content

Effect of Transcranial Direct Current Stimulation on Peripheral Neuropathy

Effect of Transcranial Direct Current Stimulation on Proprioceptive and Vibratory Sensation: Potential Benefit for Patients With Peripheral Neuropathy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03073759
Enrollment
4
Registered
2017-03-08
Start date
2016-03-31
Completion date
2020-03-31
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Neuropathy

Brief summary

This study will be performed in patients with peripheral neuropathy who are walking independently, but have complains of balance problems such as recent falls or difficulty walking and show reduced vibratory and proprioceptive sensation during routine neurologic examination. These patients will be tested for proprioceptive and vibratory threshold at the toes and ankles before, during and after receiving anodal direct transcranial cortical stimulation (dTCS) over sensory and motor cortices. Subjects will be asked to participate in 2 sessions.

Detailed description

This study will be performed in patients with peripheral neuropathy who are walking independently, but have complains of balance problems such as recent falls or difficulty walking and show reduced vibratory and proprioceptive sensation during routine neurologic examination. These patients will be tested for proprioceptive and vibratory threshold at the toes and ankles before, during and after receiving anodal transcranial direct current stimulation (tDCS) over sensory and motor cortices. Subjects will be asked to participate in 2 sessions. In one of the sessions, decided randomly, the stimulation will be applied on the right side and in the second session it will be on the left. The tDCS portion of the experiment will begins with direct current (maximum of 2 mA) stimulation delivered through surface electrodes (TransQE from IOMED®, surface area: 25 cm2) using a Phoresor® II Auto (Model No. PM850, IOMED®, Salt Lake City, Utah 84120, USA). One electrode will be positioned above the left or right primary motor cortex, the other electrode over the forehead.

Interventions

DEVICEdTCS

Direct current (DC) (maximum of 2 mA) stimulation delivered through surface electrodes. One electrode will be positioned above the left or right primary motor cortex, the other electrode over the forehead.

DEVICESham device

The device will administer a sham.

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Peripheral Neuropathy * Walking independently but with problems with balance

Exclusion criteria

* Prominent weakness at the ankle * Not able to walk independently * History of Seizure * Cardiac Pacemaker * Metal implants in the head * Increased intracranial pressure * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in Vibratory Threshold as Measured by Rydel Seiffer Graduated Tuning Fork at the ToesAt 10 and 20 minutesVibration is measured by reading in Rydel Seiffer tuning fork that ranges between 0-8 and is a standard tool fro measuring vibration sensation at the toes. A reading of 0 means absent vibration. A reading of more than 4 at the toes are considered normal. Change between assessment at 20 minutes and 10 minutes at the toes will be assessed. A recording of less than 4 indicates an abnormal results and a lower number means worse neuropathy. For example, reading of 0 means absent vibration feeling which indicates worse neuropathy than a reading of 2.
Change in Minimum Detectable Angle (Degree) of Dorsiflexion of the ToeAt 10 and 20 minutes

Countries

United States

Participant flow

Participants by arm

ArmCount
dTCS
Patients received dTCS
2
Sham
Subjects received Sham stimulation
2
Total4

Baseline characteristics

CharacteristicShamTotaldTCS
Age, Continuous67 years
STANDARD_DEVIATION 1.6
65 years
STANDARD_DEVIATION 1.78
63 years
STANDARD_DEVIATION 2
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
2 Participants4 Participants2 Participants
Sex: Female, Male
Female
1 Participants1 Participants0 Participants
Sex: Female, Male
Male
1 Participants3 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 20 / 2
other
Total, other adverse events
0 / 20 / 2
serious
Total, serious adverse events
0 / 20 / 2

Outcome results

Primary

Change in Minimum Detectable Angle (Degree) of Dorsiflexion of the Toe

Time frame: At 10 and 20 minutes

Population: Not enough patients were enrolled to reach the needed threshold to assess this outcome measure. Therefore, data was not collected.

Primary

Change in Vibratory Threshold as Measured by Rydel Seiffer Graduated Tuning Fork at the Toes

Vibration is measured by reading in Rydel Seiffer tuning fork that ranges between 0-8 and is a standard tool fro measuring vibration sensation at the toes. A reading of 0 means absent vibration. A reading of more than 4 at the toes are considered normal. Change between assessment at 20 minutes and 10 minutes at the toes will be assessed. A recording of less than 4 indicates an abnormal results and a lower number means worse neuropathy. For example, reading of 0 means absent vibration feeling which indicates worse neuropathy than a reading of 2.

Time frame: At 10 and 20 minutes

Population: Due to lack of participation for sham group, data for outcome measures in sham group was not collected.

ArmMeasureValue (MEAN)Dispersion
dTCSChange in Vibratory Threshold as Measured by Rydel Seiffer Graduated Tuning Fork at the Toes0 units on a scaleStandard Deviation 0

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026